(1)
Ha, G.; Kwong, K.; Tanaka, B.; Nishimura, Y.; Chong, C. Are Patients With HHV-8 Associated Castleman Disease Successfully Treated With Rituximab at Risk of Subsequently Developing HHV-8 Negative (idiopathic) Castleman Disease? IMCD After HHV-8-Associated MCD. EJCRIM 2023, 10.